Nurix Therapeutics, Inc. Research And Development Expense

• Nurix Therapeutics, Inc. showed an increase of +43.0% in Research And Development Expense from 2024 to 2025.
• This data is from Nurix Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on January 28, 2026.
• XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 7 years of available data (2019 to 2025), Nurix Therapeutics, Inc.'s Research And Development Expense has grown by 603.8%.
• Historical annual values: Fiscal year 2025: $316.90 million | Fiscal year 2024: $221.63 million | Fiscal year 2023: $189.15 million | Fiscal year 2022: $184.50 million | Fiscal year 2021: $116.43 million | Fiscal year 2020: $66.49 million | Fiscal year 2019: $45.03 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026